Fisetin Attenuates Arsenic-Induced Hepatic Damage by Improving Biochemical, Inflammatory, Apoptotic, and Histological Profile: In Vivo and In Silico Approach

Table 1

Presents the outcomes of biochemical analysis along with total protein content.

Groups	Control	Arsenic	Arsenic + Fisetin	Fisetin
CAT (U/mg protein)	7.62 ± 0.09^a	3.58 ± 0.26^b	6.77 ± 0.06^a	6.99 ± 0.07^a
SOD (U/mg tissue)	6.34 ± 0.12^a	3.29 ± 0.09^b	5.65 ± 0.06^a	6.19 ± 0.11^a
GSR (nm NADPH oxidized/min/mg tissue	3.03 ± 0.06^a	1.62 ± 0.16^b	2.66 ± 0.06^a	2.96 ± 0.05^a
GSH (nM/min/mg protein)	15.87 ± 0.21^a	8.99 ± 0.121^b	14.98 ± 0.07^a	15.17 ± 0.09^a
ROS (U/mg tissue)
TBARS (nM/min/mg tissue)	14.47 ± 0.2^a	22.750 ± 0.27^b	15.91 ± 0.07^a	15.16 ± 0.19^a
Total protein (µg/mg tissues)	4.04 ± 0.08^a	1.88 ± 0.06^b	3.85 ± 0.04^a	4.02 ± 0.07^a

Superscripts indicate considerable difference at probability value  < 0.05.